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Epstein-Barr  virus  (EBV) 1 is  considered,  largely on  the  basis  of  serologic  and 
epidemiologic  evidence, to be the etiologic  agent of  infectious mononucleosis (IM). 
In IM a variety of EBV-specific  antibodies appear during the course of illness (1--4), 
and absence or presence of EBV antibodies correlates with susceptiblity or resistance 
to the disease (5, 6). Furthermore, in IM, EBV is recoverable from washed leukocytes 
(7) and from oropharyngeal sites during the acute illness and for long periods there- 
after (8).2 The causal role of EBV in other disease states, such as Burkitt lymphoma, 
nasopharyngeal cancer, and sarcoidosis,  in which there are elevated EBV antibody 
titers is less certain. 
Animal experimentation has been undertaken to  investigate the  etiologic  role of 
EBV in IM, to define the oncogenic potential of EBV, to study the pathogenesis of 
EBV infections, and, perhaps, to detect differences  in EBV strains. Thus far, animal 
experiments reported  in  the  literature  have  consisted  of  heterotransplantation of 
hmnan lymphoblastoid cell lines. In neonatal or immunosuppressed rodents, lympho- 
blastoid cell lines have produced tumor masses,  but have not induced EBV antibodies 
(9).  Rhesus and marmoset monkeys inoculated with EBV-infected lymphoblastoid 
lines have not developed disease or detectable antibodies (10). 
The experimental approach in our laboratory has been to evaluate the effects 
of  inoculation of  autologous ]eukocytes  converted into  continuous cell  lines 
after in vitro exposure to EBV (11). The present report concerns the serologic 
responses of  three  squirrel monkeys that  received a  series of  inoculations of 
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autologous  EBV-converted  lymphoblasts.  The  results  suggest  that  EBV  in- 
duces  the  appearance  of  the  heterophile  antigen  of  infectious  mononucleosis 
on the cell membrane  of transformed monkey  cells. 
Materials and Methods 
Virus and Cell Lines.--Simian lymphoblastoid cell lines (SLCLs) were derived after expo- 
sure to EBV. The virus was in the form of a cell extract prepared from a human lymphoblastoid 
cell line (883L)  established from the blood of a  patient with transfusion-induced infectious 
mononucleosis. Techniques for extracting virus and for establishing and maintaining SLCL 
have been published (11). 
Animals  and  Inoculation  Schedules.  Female  squirrel  monkeys  (Saimiri  sciureus)  were 
purchased from the Tarpon Zoo, Tarpon Springs, Fla. All the monkeys initially lacked EBV 
antibodies  detectable  by  the  immunofluorescent and  complement-fixation methods.  Each 
monkey was housed in a  separate cage in the same room.  Each animal received five or six 
inoculations of 1-2 X  l0 s living (trypan blue negative) autologous EBV-transformed cells over 
a 30-day period. Cell inocula were prepared by low-speed  (800 g) centrifugation of cells from 
100 ml of tissue culture medium, washed three times with Puck's saline A, and resuspended in 
Puck's saline. 
7 mo (27 wk) after the beginning of the initial series of inoculations, another inoculation was 
given to each animal to determine whether the observed antibody responses required living 
cells or could be induced with products of disrupted cells. Animal no. 5-96 was challenged with 
1.6 X  108 washed living autologous cells; no. 5-97 received a filtrate prepared from 4.2 X  108 
washed autologous cells, suspended in Puck's saline, disrupted by repeated freezing and thaw- 
ing, and passed through a  0.8-#m Millipore filter (Millipore Corporation, Bedford, Mass.); 
no. 5-98 was given cell ghosts prepared from 6 X  l0 s autologous cells. Cell ghosts consisted of 
material found in the pellet after cells treated with three cycles of freezing and thawing had 
been centrifuged at 800 g. 7 wk later, no. 5-97 was challenged with a cell-free filtrate prepared 
from 2  X  10 s cells. 
A control animal was observed and bled in parallel with the other three animals, but was not 
inoculated. All inoculations were by the intravenous route. The inoculations are summarized in 
Table I. 
TABLE  I 
Protocol for Inoculation  and  Challenge of Squirrel  Monkeys with Epstein-Barr  Virus 
Primary inoculations  Challenge inoculation(s) 
Animal 
no.  Number  Time  after 
Material inoculated  of inocu-  first  inocu-  Material  inoculated  Titer* 
lations  lation 
wk 
5-96  Live autologous EBV-  6  27  Live autologous EBV-  3.0 
tiansformed cells  transformed cells 
5-97  Live autologous EBV-  6  27, 34  Filtrate of autologous  2.5 
transformed cells  EBV-transformed cells 
5-98  Live autologous EBV-  5  27  Ghosts of autologous  2.75 
transformed cells  EBV-transformed cells 
* LOgl0  transforming unitss0 per 0.2 ml of cell lysate  (5-96),  cell filtrate (5-97), and cell 
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Infectious  EB V in the Inocula.--The titers of virus present in whole ceils, filtrates, and ghosts 
of SLCL were quantitated by transformation assay on human umbilical-cord leukocytes. Pri- 
mary cord leukocyte cultures with 106 cells/ml were started in 15  X  150-ram glass test tubes 
(0.8 ml/tube). The medium used was RPMI 1640 plus 20% fetal calf serum. A 0.2-ml aliquot 
of material to be tested for infectivity was added to each tube. Three replicate cultures were 
inoculated for each serial decimal dilution. Transformation was recognized by the appearance 
of clusters of rapidly growing, enlarged leukocytes and by production of acid. End points were 
calculated by the Reed Muench formula. 
Observations and  Serology.--Animals  were observed daily. EBV and heterophile antibody 
levels and white cell and differential counts were measured weekly. EBV antibodies were meas- 
ured by indirect immunofluorescent  and complement-fixation  techniques (11) ; antigen for both 
tests was derived from Burkitt lymphoma cell strain HRIK. In the indirect immunofluorescent 
method, fluorescein-conjugated rabbit  antisera prepared against human  or rhesus monkey 
gamma globulin proved satisfactory in tests with squirrel monkey sera. Heterophile agglutinins 
directed against sheep red blood cells were detected in a microtiter adaptation of the Paul- 
Bunne]l method. Differential absorptions of sera were performed with guinea pig kidney (GPK) 
(Forssman) antigen and beef erythrocyte antigen (both purchased from Difco Laboratories, 
Inc., Detroit, Mich.). 
Virus Recovery Attempts.--At  five intervals from 9 to 22 wk after inoculation, peripheral 
blood was obtained from each animal. Leukocytes were prepared as described and cocultivated 
with human placental fibroblasts (11). More than 30 individual cultures were started from each 
monkey. Cultures were observed for 60 days for the appearance of transformed leukocytes. 
RESULTS 
The four animals have been observed for 8 too. None has developed palpable 
tumor  or  hematologic  abnormalities  detectable  by  differential  peripheral 
leukocyte counts. 
Serologic Responses after Initial Series of Inoculations.--The  three monkeys 
that received multiple inoculations of autologous cells  developed heterophile 
agglutinins and  EBV-specific antibodies  (Figs.  1-3).  Heterophile agglutinins 
appeared after a single inoculation (day 6) in one animal, after two inoculations 
(day 13) in a second, and not until three inoculations (day 16) in the third. At 
the time of peak titers, agglutination was present after absorption with guinea 
pig kidney antigen.  Some  early and  all  late  sera  also  contained heterophile 
agglutinins that were absorbed by guinea pig kidney antigen. As in infectious 
mononucleosis, agglutinins were entirely removed by beef erythrocyte antigen. 
Heterophile agglutinins disappeared 2-8 wk after inoculations stopped. 
EBV-specific  antibodies detectable  by complement fixation  (CF)  and im- 
munofluorescence  (IF)  appeared  after the  heterophile  agglutinins in  two  of 
three animals and after at least two inoculations; but, with the exception of a 
persistent low IF antibody titer in one animal (no. 5-96),  the EBV antibodies 
were  transient and disappeared  4-18  wk after the inoculations stopped. 
Serologic Responses  after  Challenge  after  a 7-too  Interval.--Reinoculation  of 
either autologous intact cells or cell ghosts caused the reappearance of hetero- 
phile  agglutinins;  but  filtered  cell  lysate,  given  on  two  separate  occasions, 
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resulted  from  inoculation  of  intact  cells  was  absorbed  both  by  guinea  pig 
kidney and  by beef erythrocyte antigen,  whereas  the  heterophile  agglutinins 
present after inoculation with cell ghosts were partially resistant to treatment 
with guinea pig kidney antigen. 
EBV-specific antibodies (both CF and IF) were also stimulated in anamnestic 
fashion  (6  days)  in  the  two animals given intact  cells or cell ghosts.  Only a 
low-titer IF antibody response followed inoculation of autologous cell filtrate. 
Virus Recovery Attempts.--To  determine  whether  the  animals had  become 
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FIG. 1.  Squirrel monkey no. 5-96. Heterophile and EBV-specific antibody responses after 
repeated inoculations of autologous EBV-transformed lymphoblasts; followed by challenge 7 
mo later with autologous EBV-transformed whole cells. (t-t indicates a heterophile agglutinin 
titer less than 1:4.) 
persistently infected with EBV after the initial series of intact cell inoculations, 
more  than  30  leukocyte  cultures  from each  animal  were  observed for spon- 
taneous  transformation.  No  continuous  cultures  were  established.  The  tech- 
nique was capable of detecting transformed cells in the peripheral blood, how- 
ever (we have observed spontaneous  transformation of leukocytes in cultures 
prepared very soon  [18  h]  after inoculation  of autologous transformed cells). 
DISCUSSION 
Heterophile Antibody Responses.--Although  the  results  of  the  studies  de- 
scribed  must  be  considered  preliminary because  of the  small  number of ex- 144  HETEROPItlLE  RESPONSES  IN  MONKEYS 
perimental animals used,  the data nonetheless suggest that the appearance of 
heterophile  antigen(s)  accompanies  leukocyte  transformation  by  EBV.  The 
new  heterophile  antigen(s)  are  presumably located  on  cell  membranes,  be- 
cause  cell  extracts  containing  infectious  EBV  without  membranes  did  not 
stimulate a heterophile agglutinin whereas preparations rich in cell membranes 
induced the heterophile antibody. Another explanation, which seems less likely, 
is that the heterophile antigen is a soluble cytoplasmic antigen whose immuno- 
genicity is enhanced by the presence of cell membranes. 
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FIO. 2.  Squirrel monkey no. 5-97. Heterophile and EBV-specific antibody responses after 
repeated inoculations of autologous EBV-transformed lymphoblasts; followed by two chal- 
lenges 7 and 9 mo later with filtrate of autologous transformed cells containing infectious EBV. 
(l-4 indicates a heterophile agglutinin titer less than 1:4.) 
The  new  heterophile  antigen  may  be  a  product  of the  viral  genome or it 
may be a  host cell  antigen  that is revealed in  the process of transformation. 
Burger has shown  that  baby hamster kidney cells  (BHK)  display  Forssman 
antigen activity on their surfaces not only when transformed by polyoma and 
Rous sarcoma viruses but also after brief exposure to proteases. Burger con- 
eludes  that the Forssman antigen  is present in BHK cells before virus trans- 
formation (12).  Similarly, the heterophile antigen peculiar to infectious mono- 
nucleosis may be present on normal  lymphoid cells,  but  not expressed until 
changes are brought about in the cell membrane after transformation bv EBV. 
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antigens;  rather,  differential  absorption  of the  monkey sera with  guinea  pig 
kidney and beef erythrocyte antigens suggests that two other types of hetero- 
phile  agglutinins  are present.  Sera from each inoculated  monkey contain  ag- 
gtutinins with an absorption pattern characteristic of infectious mononucleosis 
sera, i.e., agglutinins are completely removed by beef erythrocytes but not by 
guinea pig kidney antigens. However, some early and all late monkey sera with 
agglutinins demonstrate a  pattern similar to that seen in serum sickness, i.e., 
complete absorption by both guinea pig kidney and beef erythrocytes. There 
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FIG. 3.  Squirrel monkey no. 5-98. Heterophile and EBV-specific antibody responses after 
repeated inoculations of autologous EBV-transformed lymphoblasts; followed by challenge 
7 mo later with ghosts of disrupted autologous transformed cells. (H indicates a heterophile 
agglutinin titer less than 1:4.) 
may be two  different heterophile  antigens  associated with  transformation  of 
the  simian  leukocytes by EBV,  or,  alternatively,  the  animals  may have  de- 
veloped a  true  serum  sickness  as  a  result  of repeated  exposure  to  the  small 
amounts of fetal bovine serum used in the cell culture media and not removed 
by repeated washing. 
Infection  or  Immunization  with  Nonreplicating  Antigen.~--An  important 
question, Did the inoculated cells or their associated EBV replicate in the ani- 
mals?,  is not conclusively answered.  However, most of the  evidence suggests 
that both the EBV-specific antibody responses and the heterophile agglutinins 
were  due  to  immunization  with  a  considerable  antigenic  mass.  The  rapidly 146  HETEROPHILE  RESPONSES  IN  MONKEYS 
declining EBV antibody levels after cessation of inoculations and the inability 
to reisolate EBV from the blood leukocytes favor immunization without in- 
fection.  Furthermore,  in  an  experiment not  reported  in  this  series,  squirrel 
monkeys that had received one inoculation of similar numbers of autologous 
or homologous intact EBV-infected cells failed to develop EBV antibodies or 
IM-type heterophile antibodies. 
The appearance of heterophile antibodies does not seem to require cellular 
replication. For example, IM-type heterophile agglutinin has been induced in 
human volunteers by inoculation of sheep erythrocytes (13). 
Perhaps it is not surprising that we were unable to infect squirrel monkeys 
under these experimental conditions. The squirrel monkey appears to be natu- 
rally insusceptible to infection with EBV: we have detected no EBV antibodies 
in 20 animals of this species obtained from a  variety of sources, including a 
primate research center, a commercial animal dealer, and a zoo, where oppor- 
tunities for exposure to EBV presumably exist. 
Oncogenic Potential of EB V-Transformed Cells.--As noted above, most of the 
evidence suggests that the experimental animals were not infected with EBV. 
The question of the oncogenicity of EBV if the animals were infected is still 
unresolved. Our data are incomplete, for the animals are still under observation 
and have not yet been autopsied.  Furthermore, experimental viral tumor in- 
duction requires coordination of a large number of complex variables pertaining 
to both host and virus. Failure to observe any tumors at this point in the ex- 
periment might be explained, in part, by the finding that the inoculated EBV- 
transformed cells contain a strong neoantigen, the heterophile antigen. A likely 
hypothesis is  that  the  EBV-induced heterophile antigen plays an  important 
role in the surveillance of the transformed cells. 
SUMMARY 
Epstein-Barr  virus  (EBV)-transformed  autologous  lymphoblasts  were  re- 
peatedly inoculated into three squirrel monkeys. Each  animal  developed the 
heterophile antibodies of infectious mononucleosis and EBV-specific antibodies. 
After serologic responses had  disappeared or markedly declined, the animals 
were challenged with  either whole cells,  cell filtrate,  or cell ghosts.  Animals 
challenged with living cells and cell ghosts developed agglutinin responses; the 
recipient of filtrate did  not.  The  results  suggest  that  EBV  induces  the  ap- 
pearance  of  the  infectious mononucleosis heterophile  antigen  on  the  trans- 
formed cell membrane. 
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